(Q40603276)

22 September 2017

1 reference

title

Clinical comparison of adult and pediatric NeuroAIDS. (English)

1 reference

22 September 2017

Mintz M

1

1 reference

22 September 2017

publication date

1 January 1994

1 reference

Advances in neuroimmunology

22 September 2017

published in

1 reference

22 September 2017

volume

4

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

207-221

1 reference

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acoustically evoked event-related potentials in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pediatric HIV Infection: A Neuropsychological and Educational Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Vaccines in AIDS. Present state of knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pediatric acquired immunodeficiency syndrome. Neurologic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Reconstruction and future trends of the AIDS epidemic in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

HIV-1-associated psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Management of Neurologic Opportunistic Disorders in Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuromuscular diseases associated with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Mitochondrial myopathy caused by long-term zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Wernicke's encephalopathy in AIDS patient treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Lymphocyte subsets in healthy children during the first 5 years of life

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Spinal cord pathology in pediatric acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurologic signs in young children with human immunodeficiency virus infection. The European Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuronal loss in the frontal cortex in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

AIDS dementia complex complicated by cytomegalovirus encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Brainstem auditory evoked responses in infants and children with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Immunological Markers in the Cerebrospinal Fluid of HIV-1-Infected Children

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Massive neuronal destruction in human immunodeficiency virus (HIV) encephalitis. A clinico-pathological study of a pediatric case

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The neuropsychiatry of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acquired immunodeficiency syndrome in Romania

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human immunodeficiency virus-associated meningitis. Clinical course and correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurological and neuropshychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Epidemiology of Human Immunodeficiency Virus Infection and the Neurologic Complications of the Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Epidemiology of human immunodeficiency virus encephalopathy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Manic syndrome in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A model-based estimate of the mean incubation period for AIDS in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Manic syndrome early and late in the course of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Detection of HIV in fetal central nervous system tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Selective neuronal vulnerability in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Spectrum of human immunodeficiency virus-associated neocortical damage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropathological changes in early HIV-1 dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Proton MR Spectroscopy of the Brain in AIDS Dementia Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurologic Manifestations of Pediatric Acquired Immunodeficiency Syndrome: Clinical Features and Therapeutic Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Dementia associated with human immunodeficiency virus: subcortical or cortical?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human Immunodeficiency Virus-Related Cognitive Impairment and the Acquired Immunodeficiency Syndrome Dementia Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Low Education as a Possible Risk Factor for Cognitive Abnormalities in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Central Nervous System Involvement of Children with Hiv Nfection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Wernicke's encephalopathy in two patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Survival in children with perinatally acquired human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pathology of HIV-1 infection of the central nervous system. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuromuscular Complications of Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Prednisone improves human immunodeficiency virus encephalopathy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Electroencephalogram and HIV infection: a prospective study in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

HIV-1 sensitivity to zidovudine and clinical outcome in children

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Progressive multifocal leukoencephalopathy in pediatric acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neocortical damage during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Seizures in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurobehavioral outcomes in diseases of childhood: Individual change models for pediatric human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

10.1016/S0960-5428(06)80259-7

Identifiers

DOI

1 reference

22 September 2017

1 reference